Faculty Opinions recommendation of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9228956.10806055 ◽

2011 ◽

Author(s):

Bastiaan Bloem ◽

Marjolein Aerts

Keyword(s):

Parkinson’S Disease ◽

Gene Therapy ◽

Parkinson's Disease ◽

Randomised Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Download Full-text

Faculty Opinions recommendation of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9228956.10902054 ◽

2011 ◽

Author(s):

Mark Hallett ◽

Rainer Paine

Keyword(s):

Parkinson’S Disease ◽

Gene Therapy ◽

Parkinson's Disease ◽

Randomised Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Download Full-text

Faculty Opinions recommendation of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9228956.15334056 ◽

2012 ◽

Author(s):

Elena Moro

Keyword(s):

Parkinson’S Disease ◽

Gene Therapy ◽

Parkinson's Disease ◽

Randomised Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Download Full-text

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

The Lancet Neurology ◽

10.1016/s1474-4422(11)70039-4 ◽

2011 ◽

Vol 10 (4) ◽

pp. 309-319 ◽

Author(s):

Peter A LeWitt ◽

Ali R Rezai ◽

Maureen A Leehey ◽

Steven G Ojemann ◽

Alice W Flaherty ◽

...

Keyword(s):

Parkinson’S Disease ◽

Gene Therapy ◽

Parkinson's Disease ◽

Randomised Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Download Full-text

Of Monkeys and Men: Analysis of the Phase 2 Double-Blind, Sham-Surgery Controlled, Randomized Trial of AAV2-Neurturin Gene Therapy for Parkinson’s Disease

Current Neurology and Neuroscience Reports ◽

10.1007/s11910-011-0206-y ◽

2011 ◽

Vol 11 (4) ◽

pp. 345-348 ◽

Author(s):

Daniel E. Huddleston ◽

Stewart A. Factor

Keyword(s):

Parkinson’S Disease ◽

Gene Therapy ◽

Parkinson's Disease ◽

Randomized Trial ◽

Phase 2 ◽

Double Blind ◽

Download Full-text

P2.113 Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD)

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70464-x ◽

2009 ◽

Vol 15 ◽

pp. S120

Author(s):

W. Marks ◽

R. Bartus ◽

J. Siffert ◽

P. Starr ◽

J. Ostrem ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Study ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Download Full-text

Efficacy and safety of foslevodopa/foscarbidopa versus oral carbidopa/levodopa in advanced Parkinson's disease patients: Design of a phase 3, randomized, double-blind, double-dummy, active controlled 12-week trial

Journal of the Neurological Sciences ◽

10.1016/j.jns.2021.119569 ◽

2021 ◽

Vol 429 ◽

pp. 119569

Author(s):

Maurizio Facheris ◽

Weining Robieson ◽

Nahome Fisseha ◽

David Standaert

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Advanced Parkinson’S Disease

Download Full-text

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

The Lancet Neurology ◽

10.1016/s1474-4422(15)00144-1 ◽

2015 ◽

Vol 14 (8) ◽

pp. 795-803 ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Trial ◽

Phase 2 ◽

Double Blind ◽

Early Parkinson’S Disease

Download Full-text

Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

Movement Disorders ◽

10.1002/mds.10508 ◽

2003 ◽

Vol 18 (10) ◽

pp. 1149-1156 ◽

Author(s):

Yoshikuni Mizuno ◽

Nobuo Yanagisawa ◽

Sadako Kuno ◽

Mitsutoshi Yamamoto ◽

Kazuko Hasegawa ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Advanced Parkinson’S Disease

Download Full-text

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.66.4.436 ◽

1999 ◽

Vol 66 (4) ◽

pp. 436-441 ◽

Author(s):

M M Pinter ◽

O Pogarell ◽

W H Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

P1.015 Gait improvement by 60 Hertz stimulation of the subthalamic nucleus in advanced Parkinson's disease: a double blind clinical study

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70112-3 ◽

2008 ◽

Vol 14 ◽

pp. S14

Author(s):

C. Moreau ◽

P. Krystkowiak ◽

S. Bleuse ◽

F. Clement ◽

J.L. Blatt ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Study ◽

Subthalamic Nucleus ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Download Full-text